RxDoctor Payments DataLook up a doctor →

Kellie Myers, APRN

Gerontology · Houston, TXNPI 1083215800

Payments from drug & device makers

$12,668in general payments, 2019–2025

Across 518 payments — averaging $24.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AbbVie$1K
  • AstraZeneca$791
  • Bristol Myers Squibb$634
  • Novartis$538
  • Astellas Pharma US Inc$529
  • plus $8K from 54 others

What the payments were for

  • Food & beverage$11,99395%
  • Education$6755%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)58$1,383
AbbVie29$1,063
AstraZeneca(2 entities)26$791
Bristol Myers Squibb26$634
Novartis24$538
Astellas Pharma US Inc32$529
Tempus AI, Inc27$496
Pfizer23$422
Sobi, Inc12$351
Tersera Therapeutics LLC13$328
Incyte Corporation11$286
Merck14$285
E.r. Squibb & Sons, L.L.C.14$273
Takeda Pharmaceuticals U.S.A., Inc.11$256
Ipsen Biopharmaceuticals, Inc7$254
Daiichi Sankyo Inc.11$241
Rigel Pharmaceuticals, Inc.10$231
Regeneron Healthcare Solutions, Inc.6$226
Eisai Inc.9$214
Tactile Systems Technology Inc7$209
Seagen Inc.7$201
Sanofi8$196
Adaptive Biotechnologies Corporation9$193
Array Biopharma Inc8$164
Lilly USA, LLC6$148
Genentech, Inc.1$146
Bayer4$142
Springworks Therapeutics, Inc.5$138
GSK6$136
Immunogen, Inc.1$129
Gilead1$125
Pharmacyclics LLC, An Abbvie Company5$125
Jazz Pharmaceuticals Inc.4$112
Amgen6$111
Taiho Oncology, Inc.5$106
Pharmacosmos Therapeutics Inc.4$105
Morphosys, US Inc.5$99
Pharmaessentia USA Corporation4$87
Genentech USA, Inc.4$72
Caris MPI, Inc.3$69
Immunocore Limited2$68
Stemline Therapeutics Inc.3$64
Fennec Pharmaceuticals, Inc.5$60
AVEO Pharmaceuticals, Inc.3$60
Karyopharm Therapeutics Inc.3$55
Beone Medicines USA, Inc.2$50
ADC Therapeutics America, Inc.2$44
CTI Biopharma Corp.2$44
Genmab U.S., Inc.2$43
EMD Serono, Inc.2$42
Kyowa Kirin, Inc.2$40
Blueprint Medicines Corporation2$37
Puma Biotechnology, Inc.2$36
Mirati Therapeutics, Inc.2$34
Myriad Genetic Laboratories, Inc.1$28
Tolmar, Inc.1$28
Geron Corporation1$28
Dendreon Pharmaceuticals LLC1$27
Inari Medical, Inc.1$23
Menarini Silicon Biosystems, Inc.1$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,668 in reported general payments places this provider in the 95th percentile of 653 gerontology providers in Texas.

See all gerontology providers in Texas

Medicare billing

Part B allowed, 2024
$40,308
Medicare patients
239
Services billed
1,055

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban13$9,682
Ondansetron OdtOndansetron72$888
Anastrozole29$416
Lidocaine-PrilocaineLidocaine/Prilocaine19$221
Letrozole16$214
Warfarin Sodium14$171
Omeprazole14$168
Dexamethasone14$133
Escitalopram Oxalate16$126
Gabapentin14$95
Prednisone12$28
Trazodone Hcl14$27

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$422$9,68213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 653 gerontology providers in Texas.

Other gerontology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →